PHARMACEUTICAL PRODUCT DEVELOPMENT INC Capital Expenditures
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Capital Expenditures of $61.70 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire property, plant, and equipment for the quarter ending 2011-09-30 was $13.56M, a 4.11% decline year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire property, plant, and equipment for the quarter ending 2011-06-30 was $25.96M, a 62.18% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire property, plant, and equipment for the quarter ending 2011-03-31 was $22.18M, a 98.99% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire property, plant, and equipment for the quarter ending 2010-12-31 was $21.23M, a 25.20% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire property, plant, and equipment for fiscal 2010 was $62.52M, a 14.35% increase from fiscal 2009.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire property, plant, and equipment for fiscal 2009 was $54.68M, a 18.25% decline from fiscal 2008.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC payments to acquire property, plant, and equipment for fiscal 2008 was $66.88M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2011-09-30 | $13.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $39.52M derived: sum of 2 quarters · filed 2011-11-02 | $61.70M 10-Q · filed 2011-11-02 | $82.93M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-06-30 | $25.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $48.15M 10-Q · filed 2011-08-04 | $69.37M derived: sum of 3 quarters · filed 2011-08-04 | $83.51M derived: sum of 4 quarters · filed 2011-11-02 |
| 2011-03-31 | $22.18M 10-Q · filed 2011-05-03 | $43.41M derived: sum of 2 quarters · filed 2011-05-03 | $57.55M derived: sum of 3 quarters · filed 2011-11-02 | $73.56M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-12-31 | $21.23M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $35.37M derived: sum of 2 quarters · filed 2011-11-02 | $51.38M derived: sum of 3 quarters · filed 2011-11-02 | $62.52M 10-K · filed 2011-02-25 |
| 2010-09-30 | $14.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $30.15M derived: sum of 2 quarters · filed 2011-11-02 | $41.30M 10-Q · filed 2011-11-02 | $58.25M derived: sum of 4 quarters · filed 2011-11-02 |
| 2010-06-30 | $16.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $27.16M 10-Q · filed 2011-08-04 | $44.11M derived: sum of 3 quarters · filed 2011-08-04 | $58.35M derived: sum of 4 quarters · filed 2011-08-04 |
| 2010-03-31 | $11.15M 10-Q · filed 2011-05-03 | $28.10M derived: sum of 2 quarters · filed 2011-05-03 | $42.34M derived: sum of 3 quarters · filed 2011-05-03 | |
| 2009-12-31 | $16.96M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $31.19M derived: sum of 2 quarters · filed 2011-02-25 | $54.68M 10-K · filed 2011-02-25 | |
| 2009-09-30 | $14.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $37.72M 10-Q · filed 2010-11-05 | ||
| 2009-06-30 | $23.48M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | $66.88M 10-K · filed 2011-02-25 |